Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |